Audited results show strong year-over-year growth in revenue and net profit, with robust cash positions. Board approved a ₹7.99 crore preferential issue to HCAL and a ₹7 crore investment by HCAL in a subsidiary, alongside granting special rights and amending the Articles of Association.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.